0000899243-20-002328.txt : 20200129 0000899243-20-002328.hdr.sgml : 20200129 20200129200332 ACCESSION NUMBER: 0000899243-20-002328 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200129 FILED AS OF DATE: 20200129 DATE AS OF CHANGE: 20200129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roberts Christopher D. CENTRAL INDEX KEY: 0001788368 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 20559519 MAIL ADDRESS: STREET 1: C/O BLACK DIAMOND THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-01-29 0 0001701541 Black Diamond Therapeutics, Inc. BDTX 0001788368 Roberts Christopher D. C/O BLACK DIAMOND THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 10.86 2029-09-08 Common Stock 194309 D Stock Option (Right to Buy) 10.86 2029-12-04 Common Stock 54711 D 25% of the shares subject to this option shall vest and become exercisable on September 3, 2020, with the remainder vesting in 36 equal monthly installments thereafter. 25% of the shares subject to this option shall vest and become exercisable on December 5, 2020, with the remainder vesting in 36 equal monthly installments thereafter. Exhibit 24 - Power of Attorney /s/ Brent Hatzis-Schoch, as Attorney-in-Fact 2020-01-29 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                                                      Exhibit 24

                               POWER OF ATTORNEY

       Know all by these presents, that the undersigned hereby constitutes and
appoints each of Thomas Leggett, Brent Hatzis-Schoch, Marishka DeToy, and Karin
Yoo, signing singly, the undersigned's true and lawful attorney-in-fact to:

       (1)    execute for and on behalf of the undersigned, in the undersigned's
              capacity as an officer and/or director of Black Diamond
              Therapeutics, Inc., a Delaware corporation (the "Company"), (i)
              Form ID, including any attached documents, to effect the
              assignment of codes to the undersigned to be used in the
              transmission of information to the United States Securities and
              Exchange Commission using the EDGAR System, (ii) Forms 3, 4 and 5,
              (iii) Schedule 13D, (iv) Schedule 13G and (v) amendments of each
              thereof, in accordance with Section 16(a) of the Securities
              Exchange Act of 1934, as amended, and the rules thereunder;

       (2)    do and perform any and all acts for and on behalf of the
              undersigned which may be necessary or desirable to complete and
              execute any such Form 3, 4 or 5, Schedule 13D. Schedule 13G or any
              amendments thereto and timely file such form with the United
              States Securities and Exchange Commission and any stock exchange
              or similar authority; and

       (3)    take any other action of any type whatsoever in connection with
              the foregoing which, in the opinion of such attorney-in-fact, may
              be of benefit to, in the best interest of, or legally required by,
              the undersigned, it being understood that the documents executed
              by such attorney-in-fact on behalf of the undersigned pursuant to
              this Power of Attorney shall be in such form and shall contain
              such terms and conditions as such attorney-in-fact may approve in
              such attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 or Regulation 13D-G of
the Securities Exchange Act of 1934, as amended. The undersigned hereby agrees
to indemnify the attorney-in-fact and the Company from and against any demand,
damage, loss, cost or expense arising from any false or misleading information
provided by the undersigned to the attorney-in-fact.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.  This Power of Attorney may be filed with the
United States Securities and Exchange Commission as a confirming statement of
the authority granted herein. This Power of Attorney supersedes any prior power
of attorney in connection with the undersigned's capacity as an officer and/or
director of the Company.  This Power of Attorney shall expire as to any
individual attorney-in-fact if such attorney-in-fact ceases to be an executive
officer of the Company.


       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of January 29, 2020.


                                             /s/ Christopher D. Roberts
                                             -----------------------------------
                                             Christopher D. Roberts